EPICS Conference Coverage ASCO 2020 Breast Cancer Highlights

Expert perspectives on the latest therapeutic developments, treatment approaches, and implications for clinical decision-making coming out of the ASCO 2020 conference. How will emerging research affect treatment paradigms, ongoing clinical trials, and the development of new compounds?

June 3, 2020

Faculty Chair

Adam Brufsky, MD, PhD

Medical Director, Magee-Womens Cancer Program at the UPMC Hillman Cancer Center, Pittsburgh, PA, USA

Faculty Members

Pierfranco Conte, MD
University of Padua, Padua, Italy

William Gradishar, MD
Northwestern University Feinberg School of Medicine, Chicago, IL, USA

Nadia Harbeck, MD, PhD
Ludwig-Maximilians-University of Munich LMU – Breast Center, Germany

Joyce A. O’Shaughnessy, MD
Texas Oncology-Baylor Charles A. Sammons Cancer Center, TX, USA

Mark D. Pegram, MD
Stanford Cancer Institute,
Stanford, CA, USA

Sample Report

Start discovering the insights

View Report


  • Evolving Therapies for Hormone Receptor-Positive Breast Cancer
  • New Therapeutic Approaches for Early Stage and Metastatic HER2+ Breast Cancer
  • Advances in Triple-Negative Breast Cancer
  • Insights Into Immune-Based and Chemotherapy for Breast Cancer

Purchase Report

Thank you for your interest in our insights.

Complete the form below to receive additional information.